Intraocular Pressure Changes Associated With Tracheal Extubation: Comparison of Sugammadex With Conventional Reversal of Neuromuscular Blockade
NCT ID: NCT02215382
Last Updated: 2015-04-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
36 participants
INTERVENTIONAL
2014-08-31
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This prospective, randomised study was designed to compare two reversal methods with respect to changes in IOP, heart rate and blood pressure during tracheal extubation period.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sugammadex and Time to Extubation in Ophthalmic Surgery
NCT06632067
Comparison of Sugammadex Administered at 1-2 Post Tetanic Counts (PTCs) or Better With Neostigmine Administered as Per Standard of Care to Reverse Rocuronium-Induced Neuromuscular Blockade in Adults Undergoing Elective Open Abdominal Procedure (19.4.334) (P05774)
NCT00675792
Emergence Agitation
NCT07253428
Intranasal Dexmedetomidine vs Midazolam-ketamine Combination for Premedication of Pediatric Patients
NCT02072083
Effectiveness on Smooth Extubation According to the Administration Time of Sugammadex
NCT05751603
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
sugammadex
sugammadex
sugammadex 2 mg/kg
neostigmine + atropine
neostigmine+atropine
neostigmine 0,05 mg/kg + atropine 0,025 mg/kg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sugammadex
sugammadex 2 mg/kg
neostigmine+atropine
neostigmine 0,05 mg/kg + atropine 0,025 mg/kg
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* elective surgery
* endotracheal intubation under general anesthesia
Exclusion Criteria
* pregnancy
* laparoscopic surgery
* prone position
* BMI \> 30 kg/m2
* sedative drug use in last month
* patients with glaucoma.
* ASA \> II physical status
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ordu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
özgür yağan
MD, assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Anesthesiology and Reanimation Dept. Ordu University Training and Research Hospital
Altinordu, Ordu, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Odu-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.